Afortiori Development, who are specialists in the development and delivery of clinical trial strategies, have received notification, September 2019, of their ISO Accreditation BS EN ISO 9001 underlining their commitment to providing quality solutions, alongside their continued growth and expansion.
ISO 9001 certification is the most widely recognized international standard for quality management, focusing on how companies can enhance customer satisfaction through the effective application of the system, including processes for improvement and review. To earn the certification, Afortiori Development underwent a rigorous and thorough audit of its systems and processes, continuous improvement practices, and customer satisfaction efforts.
“This is a significant achievement for our business” said Elizabeth Ralph, Chief Operating Officer, “reflecting the high-quality standards of the team and our commitment to deliver optimum benefits to patients, alongside the clients and products we work hard to support”.
The ISO accreditation demonstrates a key milestone in the development of the business, which offers fully integrated solutions in the provision of professional services in clinical strategy planning, clinical trial planning, clinical trial management and clinical study reporting.
“This is also great news for our clients” said Ralph “providing them with fully accredited confidence in our services as we continue to help them reach their milestones for investment, regulatory approval and market access”.
Learn more about Afortiori Development: www.aftdev.com
